For citations:

Erdes S.F., Folomeeva O.M., Galishko E.A., Telnyh M.Y. Results of cross-sectional epidemiologic study on determination of recombinant biological agents requirement for treatment of patients with rheumatoid arthritis in real-life clinical practice. Report 1. Demographic, social, clinicaland laboratory characteristics of Russian patients with rheumatoid arthritis. Rheumatology Science and Practice. 2009;47(6):4-13. (In Russ.) https://doi.org/10.14412/1995-4484-2009-668